195 related articles for article (PubMed ID: 15342391)
41. Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer.
Zhang Y; Huang H; Zhou H; Du T; Zeng L; Cao Y; Chen J; Lai Y; Li J; Wang G; Guo Z
Cancer; 2014 Oct; 120(20):3208-18. PubMed ID: 24925528
[TBL] [Abstract][Full Text] [Related]
42. Gene expression profiles of genistein-treated PC3 prostate cancer cells.
Li Y; Sarkar FH
J Nutr; 2002 Dec; 132(12):3623-31. PubMed ID: 12468598
[TBL] [Abstract][Full Text] [Related]
43. Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis.
Marchesi F; Piemonti L; Mantovani A; Allavena P
Cytokine Growth Factor Rev; 2010 Feb; 21(1):77-82. PubMed ID: 20060768
[TBL] [Abstract][Full Text] [Related]
44. Neural cell adhesion molecule is upregulated in nerves with prostate cancer invasion.
Li R; Wheeler T; Dai H; Ayala G
Hum Pathol; 2003 May; 34(5):457-61. PubMed ID: 12792919
[TBL] [Abstract][Full Text] [Related]
45. Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model.
Siddiqui IA; Shukla Y; Adhami VM; Sarfaraz S; Asim M; Hafeez BB; Mukhtar H
Pharm Res; 2008 Sep; 25(9):2135-42. PubMed ID: 18317887
[TBL] [Abstract][Full Text] [Related]
46. Prostatic nerve subtypes independently predict biochemical recurrence in prostate cancer.
Reeves FA; Battye S; Roth H; Peters JS; Hovens C; Costello AJ; Corcoran NM
J Clin Neurosci; 2019 May; 63():213-219. PubMed ID: 30772200
[TBL] [Abstract][Full Text] [Related]
47. NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression.
McCall P; Bennett L; Ahmad I; Mackenzie LM; Forbes IW; Leung HY; Sansom OJ; Orange C; Seywright M; Underwood MA; Edwards J
Br J Cancer; 2012 Oct; 107(9):1554-63. PubMed ID: 23093296
[TBL] [Abstract][Full Text] [Related]
48. Vasa nervorum angiogenesis in prostate cancer with perineural invasion.
Ghinea N; Robin B; Pichon C; Leclere R; Nicolas A; Chnecker C; Côté JF; Guillonneau B; Radu A
Prostate; 2019 May; 79(6):640-646. PubMed ID: 30663097
[TBL] [Abstract][Full Text] [Related]
49. Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein.
Li Y; Sarkar FH
Cancer Lett; 2002 Dec; 186(2):157-64. PubMed ID: 12213285
[TBL] [Abstract][Full Text] [Related]
50. Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer.
Ding Y; He D; Florentin D; Frolov A; Hilsenbeck S; Ittmann M; Kadmon D; Miles B; Rowley D; Ayala G
Clin Cancer Res; 2013 Nov; 19(22):6101-11. PubMed ID: 24097862
[TBL] [Abstract][Full Text] [Related]
51. Pim-2 Cooperates with Downstream Factor XIAP to Inhibit Apoptosis and Intensify Malignant Grade in Prostate Cancer.
Ren K; Gou X; Xiao M; He W; Kang J
Pathol Oncol Res; 2019 Jan; 25(1):341-348. PubMed ID: 29124675
[TBL] [Abstract][Full Text] [Related]
52. MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1-cMET signaling.
Yin L; Li J; Wang J; Pu T; Wei J; Li Q; Wu BJ
Oncogene; 2021 Feb; 40(7):1362-1374. PubMed ID: 33420365
[TBL] [Abstract][Full Text] [Related]
53. [The research on the mechanism of Pim-2 suppressing the apoptosis of tumor cell].
Ren K; Shi YJ; Gong JP
Sheng Li Ke Xue Jin Zhan; 2007 Apr; 38(2):136-9. PubMed ID: 17633228
[No Abstract] [Full Text] [Related]
54. Biological correlates of prostate cancer perineural invasion diameter.
Olar A; He D; Florentin D; Ding Y; Wheeler T; Ayala G
Hum Pathol; 2014 Jul; 45(7):1365-9. PubMed ID: 24768607
[TBL] [Abstract][Full Text] [Related]
55. [Effect of aurora A on carcinogenesis of human prostate cancer].
Qu Y; Zhang L; Mu DZ; Huang X; Wei DP; Zhao FY; Liu BL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 39(1):1-5. PubMed ID: 18390187
[TBL] [Abstract][Full Text] [Related]
56. Computational Reconstruction of NFκB Pathway Interaction Mechanisms during Prostate Cancer.
Börnigen D; Tyekucheva S; Wang X; Rider JR; Lee GS; Mucci LA; Sweeney C; Huttenhower C
PLoS Comput Biol; 2016 Apr; 12(4):e1004820. PubMed ID: 27078000
[TBL] [Abstract][Full Text] [Related]
57. Spotting prostate cancer.
Neill GW; Kelsell DP
Trends Mol Med; 2001 Oct; 7(10):432. PubMed ID: 11597508
[No Abstract] [Full Text] [Related]
58. Perineural invasion of cancer: a complex crosstalk between cells and molecules in the perineural niche.
Chen SH; Zhang BY; Zhou B; Zhu CZ; Sun LQ; Feng YJ
Am J Cancer Res; 2019; 9(1):1-21. PubMed ID: 30755808
[TBL] [Abstract][Full Text] [Related]
59. The Role of Perineural Invasion in Prostate Cancer and Its Prognostic Significance.
Niu Y; Förster S; Muders M
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077602
[TBL] [Abstract][Full Text] [Related]
60. Pancreatic Tumor-Derived Extracellular Vesicles Stimulate Schwann Cell Phenotype Indicative of Perineural Invasion via IL-8 Signaling.
Gregory E; Powers I; Jamshidi-Parsian A; Griffin R; Song Y
bioRxiv; 2023 Jun; ():. PubMed ID: 37425927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
